These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

925 related articles for article (PubMed ID: 3018111)

  • 21. Platelet aggregation: its relation with ADP-induced fibrinogen binding to platelets and ADP-related membrane enzyme activities.
    Legrand C; Dubernard V; Caen J
    Eur J Biochem; 1984 Aug; 142(3):465-71. PubMed ID: 6088225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of the fibrinogen receptor on human platelets by epinephrine and the combination of epinephrine and ADP.
    Plow EF; Marguerie GA
    J Biol Chem; 1980 Nov; 255(22):10971-7. PubMed ID: 6253495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Affinity labeling of a human platelet membrane protein with 5'-p-fluorosulfonylbenzoyl adenosine. Concomitant inhibition of ADP-induced platelet aggregation and fibrinogen receptor exposure.
    Figures WR; Niewiarowski S; Morinelli TA; Colman RF; Colman RW
    J Biol Chem; 1981 Aug; 256(15):7789-95. PubMed ID: 6267026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The platelet fibrinogen receptor.
    Peerschke EI
    Semin Hematol; 1985 Oct; 22(4):241-59. PubMed ID: 2996149
    [No Abstract]   [Full Text] [Related]  

  • 25. A monoclonal antibody to the human platelet glycoprotein IIb/IIIa complex induces platelet activation.
    Modderman PW; Huisman HG; van Mourik JA; von dem Borne AE
    Thromb Haemost; 1988 Aug; 60(1):68-74. PubMed ID: 2973154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of two structurally and functionally distinct sites on human platelet membrane glycoprotein IIb-IIIa using monoclonal antibodies.
    McEver RP; Bennett EM; Martin MN
    J Biol Chem; 1983 Apr; 258(8):5269-75. PubMed ID: 6220015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retention of the glycoprotein IIb-IIIa complex in the isolated platelet cytoskeleton. Effects of separable assembly of platelet pseudopodal and contractile cytoskeletons.
    Wheeler ME; Cox AC; Carroll RC
    J Clin Invest; 1984 Sep; 74(3):1080-9. PubMed ID: 6088580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Colloidal gold labelling of fibrinogen receptors in epinephrine- and ADP-activated platelet suspensions.
    Oliver JA; Albrecht RM
    Scanning Microsc; 1987 Jun; 1(2):745-56. PubMed ID: 3616571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Normal ADP-induced aggregation and absence of dissociation of the membrane GP IIb-IIIa complex of intact rat platelets pretreated with EDTA.
    Gachet C; Stierlé A; Ohlmann P; Lanza F; Hanau D; Cazenave JP
    Thromb Haemost; 1991 Aug; 66(2):246-53. PubMed ID: 1771618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The thienopyridine PCR 4099 selectively inhibits ADP-induced platelet aggregation and fibrinogen binding without modifying the membrane glycoprotein IIb-IIIa complex in rat and in man.
    Gachet C; Stierlé A; Cazenave JP; Ohlmann P; Lanza F; Bouloux C; Maffrand JP
    Biochem Pharmacol; 1990 Jul; 40(2):229-38. PubMed ID: 2375765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamics of platelet glycoprotein IIb-IIIa receptor expression and fibrinogen binding. I. Quantal activation of platelet subpopulations varies with adenosine diphosphate concentration.
    Frojmovic MM; Mooney RF; Wong T
    Biophys J; 1994 Nov; 67(5):2060-8. PubMed ID: 7858143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of platelet GpIIb/IIIa receptors in the modulation of platelet plasminogen activator inhibitors type-1 (PAI-1) release.
    Mousa SA; Bozarth J; Forsythe M; Tsao P; Pease L; Reilly TM
    Life Sci; 1994; 54(16):1155-62. PubMed ID: 8152339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The fibrinogen-dependent pathway of platelet aggregation.
    Marguerie GA; Plow EF
    Ann N Y Acad Sci; 1983 Jun; 408():556-66. PubMed ID: 6307106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exposure of fibrinogen-binding sites on stored platelets on stimulation by aggregating agents--an electron microscopic study.
    Kitajima H; Takayama S; Yasunaga K
    Nihon Ketsueki Gakkai Zasshi; 1989 Feb; 52(1):93-101. PubMed ID: 2741653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of endothelin-1 on aggregation of normal and uremic platelets.
    Pawlak K; Małyszko JS; Małyszko J; Myśliwiec M
    Pol J Pharmacol; 1996; 48(2):185-90. PubMed ID: 9112649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modification of platelet functions by monobromobimane, a fluorescent thiol group label.
    Zucker MB; Mauss EA
    Thromb Haemost; 1986 Apr; 55(2):228-34. PubMed ID: 3012818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of a monoclonal antibody against GPs IIb-IIIa on platelet aggregation and ATP secretion.
    Balduini CL; Sinigallia F; Damiani G; Bertolino G; Bisio A; Zocchi E
    Exp Hematol; 1986 Jun; 14(5):338-42. PubMed ID: 3011483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exposure of platelet fibrinogen receptors by zinc ions: role of protein kinase C.
    Trybulec M; Kowalska MA; McLane MA; Silver L; Lu W; Niewiarowski S
    Proc Soc Exp Biol Med; 1993 May; 203(1):108-16. PubMed ID: 8475131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of epinephrine on fibrinogen receptor exposure by aspirin-treated platelets and platelets from concentrates in response to ADP and thrombin.
    Peerschke EI
    Am J Hematol; 1984 May; 16(4):335-45. PubMed ID: 6326566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of fibrinogen receptor-mediated platelet aggregation by heterologous anti-human platelet membrane antibody. Significance of an Mr = 66,000 protein derived from glycoprotein IIIa.
    Kornecki E; Tuszynski GP; Niewiarowski S
    J Biol Chem; 1983 Aug; 258(15):9349-56. PubMed ID: 6308003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.